Drug maker Lupin said on Thursday that the approval was received by the American health ruler to market generic medicines to treat diabetes. The company has received approval from the US Food and Drug Administration (USFDA) for its shortened new drug applications for liraglutide injection injection with one patient use pre-filled pens and glucagon for […]
